China dominates global API production, holding ~40% share, with projected CAGR of 6-7% through 2030 driven by demand for generics and biologics.
Key reforms emphasize quality and environmental compliance.
Major Trends
- Green Chemistry Adoption: Shift to eco-friendly processes reducing waste and emissions.
- Complex API Rise: Growth in fermentation-based and high-potency APIs for oncology/biosimilars.
- Supply Chain Resilience: Investments in domestic raw materials amid global disruptions.
- Digital Transformation: AI and automation optimizing synthesis and quality control.
These trends enhance China's API competitiveness and global supply role.